Evidence map›Paper›PMID 38221519›Full record

ArticleHuman genome variation2024

Rare mosaic variant of GJA1 in a patient with a neurodevelopmental disorder.

Rina Shimomura, Tomoe Yanagishita, Kumiko Ishiguro, Minobu Shichiji, Takatoshi Sato, Keiko Shimojima Yamamoto, Miho Nagata, Yasuki Ishihara, Yohei Miyashita, Keiko Ishigaki and 3 more

Abstract read
In one paragraph

Article in Human genome variation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rina ShimomuraDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Tomoe YanagishitaDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Kumiko IshiguroDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Minobu ShichijiDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Takatoshi SatoDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Keiko Shimojima YamamotoTransfusion Medicine and Cell Processing, Tokyo Women's Medical University, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2362-3844
Miho NagataDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Yasuki IshiharaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Yohei MiyashitaDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Keiko IshigakiDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Satoru NagataDepartment of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Yoshihiro AsanoDepartment of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Toshiyuki YamamotoDivision of Gene Medicine, Graduate School of Medical Science, Tokyo Women's Medical University, Tokyo, Japan. yamamoto.toshiyuki@twmu.ac.jp.ORCID http://orcid.org/0000-0002-9484-3505

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GJA1 is the causative gene for oculodentodigital dysplasia (ODDD). A novel de novo GJA1 variant, NM 000165:c263C > T [p.P88L], was identified in a mosaic state in a patient with short stature, seizures, delayed myelination, mild hearing loss, and tooth enamel hypoplasia. Although the patient exhibited severe neurodevelopmental delay, other clinical features of ODDD, including limb anomalies, were mild. This may be due to differences in the mosaic ratios in different organs.

Identifiers

PMID38221519
PMCPMC10788341

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.